What it's for (Indications)
- Sodium acid citrate is primarily indicated for the treatment and prevention of certain conditions requiring urinary alkalinization.
- This includes the management of renal tubular acidosis (RTA) with calcium stones, where it helps correct systemic acidosis and reduces stone formation.
- It is also extensively used for the prevention of uric acid nephrolithiasis, by increasing the solubility of uric acid in the urine and preventing its precipitation into crystals or stones.
- Furthermore, it aids in the prevention of cystine calculus formation in patients with cystinuria, by increasing the urinary pH to improve cystine solubility.
- In some cases, it may be used as an adjunct for symptomatic relief in urinary tract infections by reducing irritation from acidic urine, though it does not treat the infection itself.
- Its application extends to alkalinizing urine to enhance the excretion of certain acidic drugs or to mitigate the nephrotoxicity of particular medications.
- The precise indication and duration of therapy should always be determined by a qualified healthcare professional based on individual patient needs and clinical assessment.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of sodium acid citrate must be individualized based on the patient's specific clinical condition, the desired urinary pH, and their metabolic response. Typically, the goal is to maintain a urinary pH between 6.0 and 7.0, depending on the underlying indication. For adults, a common starting dose might involve 10-30 mL (equivalent to 2-6 mEq of citrate) diluted in water, administered orally three to four times daily, preferably after meals and at bedtime to minimize gastrointestinal upset. Pediatric dosing is significantly lower and must be carefully calculated per kilogram of body weight, ensuring close monitoring. The dosage should be adjusted gradually by the treating physician, guided by frequent monitoring of urinary pH using nitrazine paper or a pH meter, as well as periodic assessment of serum electrolytes, especially sodium and bicarbonate levels. It is crucial for patients to adhere to the prescribed regimen and not to alter the dose without medical consultation to avoid potential complications. |
Safety & Warnings
Common Side Effects
- While generally well-tolerated when administered appropriately, sodium acid citrate can induce a range of side effects, primarily affecting the gastrointestinal system.
- Common adverse effects include nausea, vomiting, diarrhea, and abdominal discomfort, which can often be mitigated by taking the medication with meals and ensuring adequate dilution with water.
- More serious, albeit less common, side effects are typically associated with excessive dosage or pre-existing conditions that impair the body's ability to handle electrolyte and acid-base balance.
- These may include metabolic alkalosis, characterized by symptoms such as muscle weakness, confusion, or tingling sensations, due to the over-alkalinization of the blood.
- Furthermore, due to its sodium content, there is a risk of hypernatremia (elevated blood sodium levels) and fluid retention, which can be particularly concerning for patients with underlying cardiac or renal dysfunction, potentially exacerbating edema or congestive heart failure.
- Careful monitoring of electrolyte levels is essential to prevent these complications.
Serious Warnings
- Black Box Warning: **Serious Warnings: Risk of Electrolyte Imbalance and Metabolic Alkalosis** While sodium acid citrate does not carry a formal FDA Black Box Warning, healthcare professionals and patients must be acutely aware of significant risks, particularly concerning electrolyte imbalances and metabolic alkalosis. Administration of this medication, especially in high doses or in individuals with compromised renal function, can lead to severe hypernatremia (excessively high sodium levels in the blood) and metabolic alkalosis (excessively high blood pH). These conditions can precipitate or exacerbate serious adverse events, including cardiac arrhythmias, muscle weakness, severe confusion, and seizures. Patients with pre-existing cardiovascular disease, such as congestive heart failure, severe hypertension, or myocardial damage, are at an elevated risk of fluid overload and pulmonary edema due to the substantial sodium content of the formulation. Renal impairment significantly increases the risk of these complications by impeding the body's ability to excrete excess sodium and bicarbonate. Consequently, meticulous monitoring of serum electrolyte levels (sodium, potassium, bicarbonate), renal function, and acid-base status is absolutely mandatory throughout the course of treatment, particularly in vulnerable patient populations. Any signs of electrolyte disturbance or worsening cardiac/renal status warrant immediate medical attention and potential cessation of therapy.
- Sodium acid citrate should be used with extreme caution in patients with conditions that may be adversely affected by increased sodium intake or metabolic alkalosis.
- This includes individuals with severe myocardial damage, chronic heart failure, or uncontrolled hypertension, where the added sodium load can precipitate or worsen fluid retention, edema, and cardiac decompensation.
- Patients with impaired renal function are at a significantly higher risk of developing hypernatremia and metabolic alkalosis due to their reduced ability to excrete excess sodium and bicarbonate.
- Careful monitoring of serum electrolytes, renal function (e.
- g.
- , creatinine, BUN), and acid-base status is imperative throughout treatment.
- Concomitant use with potassium-sparing diuretics should be avoided due to the theoretical risk of hyperkalemia if other potassium salts are present in the formulation or if there's a predisposition.
- The drug can also interact with other medications, altering their excretion or efficacy; for example, it can decrease the excretion of basic drugs like quinidine and ephedrine, potentially increasing their effects, and increase the excretion of acidic drugs like salicylates.
- Pregnancy and breastfeeding require careful consideration, with use only if clearly indicated and under strict medical supervision.
How it Works (Mechanism of Action)
Sodium acid citrate functions primarily as a systemic and urinary alkalinizing agent. Upon oral administration, the citrate ion is readily absorbed from the gastrointestinal tract and subsequently metabolized in the liver, primarily through the Krebs cycle. This metabolic process consumes hydrogen ions and produces bicarbonate ions (HCO3-). The increased systemic bicarbonate load leads to an elevation in blood pH, correcting metabolic acidosis if present. More importantly for its urological applications, the excess bicarbonate is filtered by the kidneys and excreted into the urine, thereby increasing the urinary pH. This elevation in urinary pH significantly enhances the solubility of uric acid and cystine, reducing their tendency to precipitate and form stones. For example, at a urinary pH of 6.5, uric acid is largely ionized and much more soluble than at acidic pH levels, preventing or dissolving uric acid crystals. This mechanism also impacts the reabsorption and excretion of certain medications, influencing their therapeutic effects and potential toxicities.